Research

Displaying 1 - 10 of 285

Microneedle contraceptive patch to empower world’s poorest women

Microneedle contraceptive patch to empower world’s poorest women
Innovative microneedle technology is being developed as an effective, pain-free and discreet method of delivering contraception across the world’s poorest countries, thanks to a new research consortium led by Cardiff University and supported by the Bill & Melinda Gates Foundation. The project will focus on pre-clinical work to develop microneedle patches that have the potential to be painlessly and inconspicuously administered by the user themselves within a few seconds and can last for up to six months. 
15th January 2019

Milestone in development of latenium technology

Milestone in development of latenium technology
It has been announced that G-ray Switzerland and CSEM have achieved a major milestone in packaging the latenium technology to deliver X-ray imaging solutions with the latenium Evaluation Kit. Centred on particle-counting X-ray imaging, these solutions are set to improve the quality of the images obtained from examinations such as breast cancer screening helping earlier detection and reducing the radiation doses currently needed for mammography. 
21st December 2018

Looking for ways to measure tumour aggression

Looking for ways to measure tumour aggression
Researchers at University Putra Malaysia found a relationship between some markers of inflammation in the body and the aggressiveness of certain malignant tumours. They conducted full body scans of 31 people with malignant tumours, including cancers of the lung, oesophagus, colon and breast, using a machine that combines positron emission and computed tomography (PET/CT).
18th December 2018


AI tool can improve best practises in managing nut allergies

AI tool can improve best practises in managing nut allergies
The UK based technology start-up, Spoon Guru, has released a revealing new study, conducted with assistance from the British Dietetic Association. The study affirms that Spoon Guru’s pioneering AI technology can perform as precisely as qualified healthcare professionals in recommending foods suitable for people with nut allergy. 
14th September 2018

Biomarker analysis for the largest cohort study in Latin America

Biomarker analysis for the largest cohort study in Latin America
Nightingale Health will perform large-scale metabolic profiling of the Mexico City Prospective Study cohort by analysing the biomarker profiles of blood samples from a cohort of 150,000 study participants. Contracted by the Nuffield Department of Population Health at the University of Oxford, Nightingale will provide novel biomarker data to accelerate research into the chronic disease risk of Hispanic populations.
4th September 2018

Facebook and NYU launch collaboration to improve MRI

Facebook and NYU launch collaboration to improve MRI
Facebook and NYU School of Medicine’s Department of Radiology have announced fastMRI, a new collaborative research project that will investigate the use of artificial intelligence (AI) to make magnetic resonance imaging (MRI) scans up to 10 times faster. If this effort is successful, it will make MRI technology available to more people, expanding access to this key diagnostic tool.
22nd August 2018

Research shows that glaucoma may be an autoimmune disease

Research shows that glaucoma may be an autoimmune disease
Glaucoma, a disease that afflicts nearly 70 million people worldwide, is something of a mystery despite its prevalence. Little is known about the origins of the disease, which damages the retina and optic nerve and can lead to blindness. A study from MIT and Massachusetts Eye and Ear has found that glaucoma may in fact be an autoimmune disorder. In a study of mice, the researchers showed that the body’s own T cells are responsible for the progressive retinal degeneration seen in glaucoma.
15th August 2018

Researching the physical properties of giant cancer cells

Researching the physical properties of giant cancer cells
Polyploidal cancer cells—cells that have more than two copies of each chromosome—are much larger than most other cancer cells, are resistant to chemotherapy and radiation treatments and are associated with disease relapse. A new study by Brown University researchers is the first to reveal key physical properties of these 'giant' cancer cells.
14th August 2018

How 3D printers could improve access to technology

How 3D printers could improve access to technology
3D printers can make just about anything these days, from a pair of running shoes to chocolate, wood, and aircraft parts. And it turns out — even complex scientific gadgets used in cancer research. Cost-efficient tools are essential in life sciences research to understand how cancer cells migrate from one place to another during metastasis, to probe how neurons connect in networks during human development, and to watch how white blood cells respond to infections.
10th August 2018

Method reveals how well cancer drugs hit their targets

Method reveals how well cancer drugs hit their targets
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumour in real time, revealing which cells interact with the drug and which cells the drug fails to reach. In the future, the findings, published in Nature Communications, could help clinicians decide the best course and delivery of treatment for cancer patients.
18th July 2018


Research documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Southern Manufacturing & Electronics 2019
5th February 2019
United Kingdom Farnborough
embedded world 2019
26th February 2019
Germany Nuremberg
Wearable Tech Show 2019
12th March 2019
United Kingdom London
AMPER 2019
19th March 2019
Czech Republic Brno Exhibition Centre